Fenofibrate Potentiates the Antihyperglycemic, Antidyslipidemic and Hepatoprotective Activity of Pioglitazone in Alloxan-Induced Diabetic Rats
Journal Title: Journal of Pharmaceutical Research International - Year 2016, Vol 9, Issue 6
Abstract
Aim: The present research was designed to investigate the hypoglycemic, hypolipidemic and hepatoprotective activity of the fixed dose combination of pioglitazone and fenofibrate. Methodology: For the study purpose, pioglitazone at a dose of 15 mg/70 kg body weight (BW) and fenofibrate at a dose of 72.5 mg/70 kg BW were administered on alloxan (120 mg/kg BW) induced diabetic rats. Both the drugs (pioglitazone and fenofibrate), singly and in combination, separately were tested in vivo for 14 days (two weeks) to determine blood glucose level, lipid profile and hepatoprotective activity using Long-Evans male rats as test animals. In addition, to investigate any possible side effects of the combined therapy, the survival rate of rats were also measured. Results: The study showed that in alloxan induced diabetic rats, combination therapy significantly decreased the blood glucose level from 16.00±0.01 to 7.85±0.03 mmol/L two hours later of last dose administration in comparison to the diabetic control group, after daily treatment for two weeks. In case of dyslipidemic effect, combination therapy reduced total cholesterol level by 31%, triglyceride level by 46% and LDL-cholesterol level by 37% significantly and increased HDL-cholesterol level by 77% in comparison with their respective diabetic control groups. It was also observed that combination therapy decreased alanine transaminase (ALT) level by 53% and aspartate transaminase (AST) level by 40% in comparison to diabetic control group effectively. These changes were significantly better than those of pioglitazone and fenofibrate monotherapy. No rats were died after combined treatment while the survival rates were 80%, 80% and 60% for pioglitazone, fenofibrate and diabetic groups (alloxan induced) respectively. Conclusions: Our study suggests that the combination of pioglitazone and fenofibrate might be efficacious in patients with diabetic dyslipidemia and might provide better hepatoprotective activity in these patients.
Authors and Affiliations
Md. Tanjir Islam, Md. Shahid Sarwar, A. F. M. Towheedur Rahman, Md. Asaduzzaman, Yusuf Ali, Shaheda Zannah, Mamunur Rashid
Keywords
Related Articles
- EP ID EP342367
- DOI 10.9734/BJPR/2016/22664
- Views 98
- Downloads 0
Purification and Structure Elucidation of the Polyether Antibiotic Alborixin from Streptomyces pulcher CRF17
Aims: To screen Streptomyces sp. from saline soil in Pakistan, for its antimicrobial activity and to purify and identify the active metabolites produced by mass spectrometry and NMR spectroscopy. Strain identification by...
Use of Mobile Phones for Monitoring Adverse Drug Reaction in Pharmacy and Drug Stores in Ishaka, Uganda - a Pilot Assessment of Willingness to Report
Aim: We investigated reporting of Adverse Drug Reaction (ADR) following use of drugs purchased from open system pharmacy (OSP) and drug stores, and the effectiveness of mobile phones for reporting drug reactions and dete...
Validated UV Spectrophotometric Methods for the Estimation of Olanzapine in Bulk, Pharmaceutical Formulations and Preformulation Studies
Aims: To develop and validate two accurate and precise UV spectrophotometric methods for the estimation of widely prescribed anti psychotic drug-Olanzapine in bulk, formulations and preformulation studies. Methodology:...
Antifilarial Activity of Cucurbita pepo ovifera var ovifera (Cucurbitaceae) on Onchocerca ochengi Adult Worms
One of the strategies for developing novel pharmaceutical drugs is to use natural sources such as plants for therapeutic treatment. Plant extracts are a cocktail of compounds which act synergically and can improve treatm...
Comparative Quality Control Evaluation of Atenolol Tablets Marketed in Kuala Lumpur, Malaysia
Background: The emergent of many pharmaceutical companies producing their own generic type of drugs after the patent of innovator drugs expired can improve the general healthcare delivery systems as well as decreasing th...